ArticleFrontiers in neurology2019
Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis.
Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 8 citations in OpenAlex.
- Quantitative Analysis of Smooth Pursuit and Saccadic Eye Movements in Multiple Sclerosis.Neurology international · 2026Article
- Visual impairment in multiple sclerosis involving post-geniculate gray and white matter: above and beyond.Frontiers in neurology · 2026Review
- Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance.Frontiers in neurology · 2021Article
- DenseLes: slice-wise dense network for multiple sclerosis lesion segmentation and classification.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eye movement deficits are frequently noted in multiple sclerosis during bedside clinical examination, but subtle dysfunction may remain undetected and might only be identified with advanced approaches. While classical neurology provides insight into the complex functional anatomy of oculomotor functions, little is known about the structural background of this dysfunction in MS. Thirty four clinically stable, treated relapsing-remitting MS patients with mild disability and 34 healthy controls were included in our study. Group difference and correlation with clinical parameters were analyzed in case of the latency, peak-velocity, gain, dysconjugacy index, and performance during a saccade and anti-saccade task. High-resolution T1 weighted, T2 FLAIR, and double inversion recovery images were acquired on 3T to evaluate the correlation between behavioral and MRI parameters, such as T2 lesion and T1 black-hole burden, global brain, gray, and white matter atrophy. VBM style analysis was used to identify the focal gray matter atrophy responsible for oculomotor dysfunction. Significantly increased latency in the prosaccade task and significantly worse performance in the anti-saccade task were found in MS patients. The detailed examination of conjugated eye movements revealed five subclinical internuclear ophthalmoparesis cases. The peak velocity and latency of the anti-saccade movement correlated with the number of black holes, but none of the eye movement parameters were associated with the T2 lesion burden or location. Global gray matter volume correlated with saccade and anti-saccade latency, whereas white matter and total brain volume did not. Local gray matter atrophy in the left inferio-parietal lobule and temporo-occipital junction correlated with anti-saccade peak velocity. Our results show that neurodegeneration-like features of the MRI (black-hole, gray matter atrophy) are the best predictors of eye movement deficit in MS. Concurring with the clinico-radiological paradox, T2 lesion burden cannot explain the behavioral results. Importantly, anti-saccade peak velocity correlates with gray matter atrophy in the left parietal regions, which are frequently implicated in attention tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.